Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Neuberger Berman is evaluating an expansion of its insurance capabilities that could include establishing an entity able to purchase life insurance assets, according to people familiar with the matter. The review is exploratory, with no certainty the firm will pursue the plan. The move reflects a wider trend of asset managers seeking fee income and…
A Reuters poll of 44 market strategists, analysts and portfolio managers finds the median forecast for the S&P 500 at about 7,500 by the end of 2026, roughly a 9.7% gain from the index's close on Monday at 6,837.75. Forecasters cite upbeat U.S. earnings and steady economic growth as primary drivers, while noting risks from inflation and Federal Res…
Stifel raised its price target on Palvella Therapeutics to $250 from $180 and kept a Buy rating after the company reported positive Phase 3 SELVA trial results for QTORIN 3.9% rapamycin gel in microcystic lymphatic malformations. The trial met all primary and secondary endpoints with high statistical significance, producing clinically meaningful im…
BofA Securities raised its price target for Beam Therapeutics Inc. (BEAM) to $47 from $45 while maintaining a Buy rating. The firm pointed to updates across Beam’s liver-targeted in vivo editing platform - including a new PKU program, momentum in a Pfizer collaboration, and FDA alignment on an accelerated pathway in AATD - as underpinning the move.…
Claudio Tuozzolo, a vice president at Vicor Corp (NASDAQ: VICR), sold 4,469 shares on February 23, 2026, at $174.6037 per share for a total of $780,303. After the sale he holds 29,153 shares. The transaction occurred while the stock trades close to its 52-week high and after a 185% gain over the past year. InvestingPro analysis describes the shares…
Avantor's recent pullback centers on a large goodwill impairment, softer biopharma demand and litigation headlines. The market cap now sits near $6.1B while free cash flow remains roughly $495M, implying a double-digit FCF yield and a valuation that looks forgiving for a company with a working balance sheet and buyback authorization. This trade ide…
Wolf Research screened the S&P 500 Dividend Aristocrats to surface 10 companies that combine solid dividend-growth characteristics with financial stability. The firm filtered for above-market dividend growth, second-quintile yields or steady repurchase programs and excluded firms showing high leverage or signals of dividend stress. The selected fir…
Alcoa said it intends to sell 10 closed or curtailed facilities to operators in the data centre industry, with the company targeting a first closing by the end of June and potential follow-on sales soon after. The announcement coincided with a 4% increase in the aluminium producer's share price and reflects management's efforts to convert underused…
Bank of America upgraded Keysight Technologies to Buy from Neutral and increased its price target to $340, citing materially stronger-than-expected order growth and an elevated earnings outlook. The test and measurement company reported a 22% year-over-year increase in core orders for the fiscal first quarter and raised its fiscal 2026 adjusted EPS…
CarGurus (CARG) shares rose 4% on Thursday as investor fears about artificial intelligence competition in the software arena eased. The gain followed an earlier pullback that occurred after Anthropic emerged as a perceived threat to software companies, prompting scrutiny of CarGurus' expanding software initiatives. Huber Research characterized the …
Colgate-Palmolive has informed a conservative shareholder group it intends to oppose a proposal seeking to eliminate race, gender and sexual orientation from criteria used to identify future board members. The company says the proposal would inappropriately constrain its nominating committee and stresses that diverse perspectives are important to s…
Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp, recorded a one-share purchase on February 23, 2026, at $519.85 per share, according to a Form 4 filing. The firm now directly holds 3,479,378 shares. The trade coincides with a strong run for TPL shares, valuation metrics flagged by InvestingPro, a quarterly ear…
Raymond James upgraded Genuine Parts Company from Outperform to Strong Buy and established a $145 price target based on a sum-of-the-parts analysis tied to the planned split of its Auto and Industrial businesses. The firm argues the market is undervaluing the Auto operations relative to peers, and projects the separation to close by the first quart…
Shares of Reitar Logtech Holdings Limited (NASDAQ:RITR) fell 9% on Tuesday after the company disclosed a non-binding memorandum of understanding for a possible $60 million equity investment. The arrangement, proposed with Equator Capital Management SPC acting for Equator Private Equity Fund SP, would fund Reitar's participation in a consortium seek…
Alcoa Corp is seeking buyers from the data centre sector for 10 of its closed or curtailed aluminium sites, with its CEO saying the company expects the first sale to close by the end of June. The move reflects rising demand for power-adjacent real estate from data centres and raises questions about how AI-driven data centre growth could alter asset…
U.K. equities closed marginally lower on Tuesday, with the United Kingdom 100 index down 0.03% as losses in fixed-line telecommunications, REITs and automobile parts companies weighed on the market. While several mid-cap stocks posted strong gains, a handful of larger declines, including a steep fall in a major landlord, helped push the benchmark s…
Edesa Biotech's stock rose sharply after the company disclosed additional Phase 3 data for paridiprubart that indicate statistically significant reductions in adjusted 28-day mortality across an expanded patient cohort. The dataset covers 278 patients, including those who were and were not on invasive mechanical ventilation, and shows consistent sa…
Spain's benchmark index ended Tuesday's session in negative territory, dragged down by losses in Financial Services & Real Estate, Telecoms & IT and Consumer Services. The IBEX 35 closed down 0.54% in Madrid, even as several large-cap utilities and industrials posted strong gains and hit multi-year or record highs.
Portugal's main equity index, the PSI, closed higher on Tuesday, rising 0.25% to reach a new five-year high. Gains were concentrated in the Utilities, Consumer Goods and Telecoms sectors, with EDP Renovaveis, EDP and Ibersol among the top performers. Banking, postal and energy names finished lower. Commodity prices slipped and major currency pairs …
The AEX index closed higher on Tuesday, rising 0.34% to a fresh record high as stocks in the Healthcare, Technology and Oil & Gas sectors pushed the market up. Market breadth was mixed with slightly more decliners than advancers. Key individual movers included Wolters Kluwer, Magnum Ice Cream and BE Semiconductor Industries on the upside, while ABN…
Italian equities finished marginally lower after the close on Tuesday, with the Investing.com Italy 40 slipping 0.05% in Milan. Sector declines in Financials, Telecoms and Oil & Gas were cited as the primary drags. Notable winners included Ferrari, Lottomatica and Leonardo, while several regional banks led the decliners. Commodity and currency mark…
German equities finished slightly higher on Tuesday, with the DAX up 0.12% at the close as Technology, Utilities and Food & Beverages names provided upward momentum. The MDAX and TecDAX also rose, led by selected rallies in semiconductor and specialty chemical names, while several healthcare and industrial stocks posted notable declines. Market vol…
Sarepta Therapeutics' stock climbed after Chugai Pharmaceutical initiated commercial sales of ELEVIDYS in Japan subsequent to its listing on Japan’s National Health Insurance price list. The launch activates a $40 million milestone payment to Sarepta under its collaboration with Roche. ELEVIDYS is the first gene therapy approved and launched in Jap…
Paris equities finished higher on Tuesday, with the benchmark CAC 40 closing at a new all-time high after modest sector-led advances. Euronext, Stellantis and Renault were among the index leaders, while Safran, BNP Paribas and Herms weighed on the market. The broader SBF 120 registered larger winners in Eramet, Valneva and Technip Energies, even as…
Belgian equities ended higher after the close on Tuesday, with the benchmark BEL 20 index rising 0.43%. Gains were led by the Basic Materials, Utilities and Technology sectors, while market breadth favored rising issues over decliners. Commodity prices and major currency pairs showed modest movements alongside a slight uptick in the dollar index.
